Search Results 521-530 of 17044 for Aprepitant

  1. Clinical trials - Oncology (Medical)

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

  2. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...

  3. Abrocitinib (oral route) - Side effects & dosage - Mayo Clinic

    Abrocitinib is used to treat moderate to severe atopic dermatitis (eczema) in patients who have taken other medicines that did not work well and whose condition ...

  4. Clinical trials - Oncology (Medical)

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  5. Aflibercept-mrbb (intraocular route) - Mayo Clinic

    Aflibercept-mrbb injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes ...

  6. Panitumumab (intravenous route) - Side effects & uses - Mayo Clinic

    Panitumumab injection is used alone or in combination with other medicines to treat metastatic cancer (cancer that spreads to other parts of the body) of the ...

  7. Neurosurgery - Clinical trials

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...

  9. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  10. Datopotamab deruxtecan-dlnk (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Datopotamab deruxtecan-dlnk injection is used to treat non-small cell lung cancer (NSCLC) that has spread to areas outside of the lungs ...